Learning Community: The Role of Anti-Obesity Medications in T2DM Management
Updated: 01/17/24
Watch the Recorded Talk
Presented November 17, 2023
Dina Griauzde, MD, MSc Assistant Professor, Department of Internal Medicine University of Michigan, VA Ann Arbor Healthcare System; Diplomate, American Board of Obesity Medicine; Research Director, Michigan Medicine Weight Navigation Program; Co-medical Director, Weight Management and Metabolic Health Program, VAAAHS
Objectives
Pathophysiologic link between obesity and T2DM
Mechanism of action, efficacy, and safety of incretin mimetics for the
treatment of obesity
Role for older anti-obesity medications in patient-centered obesity treatment
Case examples
Download Dr. Griauzde's Presentation Slides
Tags: Created By MCT2D, Video, For Providers, VBR Learning